NEW YORK, Oct. 26 (GenomeWeb News) - Genomas launched its HILOmet PhysioType System and announced a distribution agreement with Newington, Conn.-based Clinical Laboratory Partners, the company said today.
Similar to Roche Diagnostic's AmpliChip CYP450 test, based on Affymetrix's Gene Chip technology that was approved late last year, the HILOmet System uses DNA-based typing of 3 cytochrome p450 genes, CYP 2C9, 2C19, and 2D6 to determine individual rates of drug metabolism.
The company's Laboratory of Personalized Health will perform the HILOmet tests.
"Blood samples will be drawn by our phlebotomists at our many facilities throughout Connecticut and sent to the LPH," George M. Kyriacou, president of Clinical Laboratory Partners, said in a statement. LPH and CLP will provide DNA typing reports to the physicians.
Gulaberto Ruaño, a former vice chairman and chief scientific officer of Genaissance, launched Genomas in 2003 to study individual genetic responses to stress, exercise, climate, and disease.